Applications:
 Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen)
 
 
 
 Research Discipline:
 Apoptosis, Cancer, Cytokine Research, Zinc Finger
 
 Formulation:
 Whole antisera with 0.05% Sodium Azide
 
 
 Immunogen:
 A synthetic peptide corresponding to amino acids 87-106 (SSSAFPDNAARREVESLPAV) of human TRAF2 was used as immunogen, GenBank no. NP_066961.2. This peptide sequence is 100% conserved in mouse and rat TRAF2. The peptide immunogen sequence is 100% conserved in multiple human TRAF2 GenBank accession numbers. These TRAF2 accession numbers are of varying amino acid (aa) lengths and include: 1. NP_066961.2 = 501 aa. 2. CAI12705.1 =121 aa. 3. CAI12704.1 = 422 aa. 4. CAI15104.1 = 193 aa. 5. BAD96681.1 = 205 aa.
 
 Primary or Secondary:
 Primary
 
 Content And Storage:
 Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
 
 Dilution:
 Western Blot 1/1000 - 1/200, Immunohistochemistry, Immunocytochemistry/Immunofluorescence reported in scientific literature (PMID 33471802), Immunoprecipitation, Immunohistochemistry-Paraffin 1/1000 - 1/500, Immunohistochemistry-Frozen Use at an assay dependent dilution
 
 Classification:
 Polyclonal
 
 
 
 Target Species:
 Human, Mouse, Rat
 
 Gene Alias:
 E3 ubiquitin-protein ligase TRAF2, EC 6.3.2.-, MGC:45012, TNF receptor-associated factor 2, TRAP3TRAP, tumor necrosis factor type 2 receptor associated protein 3, Tumor necrosis factor type 2 receptor-associated protein 3
 
 
 
 Purification Method:
 Unpurified
 
 Test Specificity:
 The gene encoding TRAF2 produces, by alternative splicing, 15 different transcripts, all with introns, putatively encoding 15 different protein isoforms. These isoforms are of varying amino acid lengths. Therefore the molecular weight observed by western blot may vary, depending on the isoform expressed. Users are encouraged to use the peptide immunogen sequence information provided in the antigen section to gain additional information about the potential TRAF2 isoforms detected by the antibody.